The Blood–Glaucoma Connection
Could red blood cells help predict glaucoma?
A recent study from the University of Electronic Science and Technology of China identifies a novel systemic factor in glaucoma: increased erythrocyte osmotic fragility (EOF). This condition, which reflects the mechanical fragility of red blood cells, was found to be significantly elevated in glaucoma patients, potentially serving as an innovative blood-based biomarker. The study revealed a strong correlation between EOF and glaucoma severity, suggesting systemic inflammation and oxidative stress may contribute to retinal ganglion cell vulnerability, and proposes EOF testing as a promising tool for earlier detection and risk stratification.
1. Glaucoma defined by optic neuropathy and visual field loss, potentially with normal IOP. 2. Study links erythrocyte osmotic fragility (EOF) to glaucoma severity. 3. Increased EOF correlates positively with disease severity. 4. EOF testing may serve as a novel blood-based biomarker. 5. Involves a case-control analysis of 175 patients and healthy controls. 6. Further studies required for clinical utility. 7. EOF abnormalities may precede structural damage. 8. EOF testing is technically simple and low-cost.
